SPI-2012

null · Spectrum Pharmaceuticals, Inc

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SPI-2012, covering 2022-03-02 to 2022-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer [Phase 2]

See pricing